Functional improvement after subthalamic stimulation in Parkinson's disease: A non-equivalent controlled study with 12-24 month follow up

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 6, 2005, Pages 769-774

  Capecci, M ^a   Ricciuti, R A ^b   Burini, D ^a   Bombace, V G ^a   Provinciali, L ^a   Iacoangeli, M ^b   Scerrati, M ^b   Ceravolo, M G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; DRUG EFFICACY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DEEP BRAIN STIMULATION; DEMOGRAPHY; DEPRESSION; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; PERIODICITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; SUBTHALAMIC NUCLEUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 20444368411     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.047001     Document Type: Article

References (56)

1. Task force of the Movement Disorder Society. Management of Parkinson's Disease: an evidence-based review. Mov Disord 2002;17(suppl 5):S3-S386.
2. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-Brain stimulation of the subthalamic nucleus or the pars interna or the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
3. Pollak P, Fraix V, Krack P, et al. Treatment results: Parkinson's disease. Mov Disord 2002;17(suppl 3):S75-83.
4. Siderowf AD, Holloway RG, Stern MB. Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions. Mov Disord 2000;15:439-45.
5. Spottke EA, Volkmann J, Lorenz D, et al. Evaluation of Healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. J Neurol 2002;249:759-66.
6. Lang AE, Widner A. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002;15(17, S3):S94-S101.
7. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson's disease: a multidisciplinary approach. Arch Neurol 2000;57:461-5.
8. Deuschl G, Wenzelburger R, Kopper F, et al. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a therapy approaching evidence-based standards. J Neurol 2003;250(suppl 1):143-6.
9. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-11.
10. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-84.
11. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale in Recent Developments. In: Fahn S, Marsden CD, Calne DB, et al. eds. Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information, 1987:153-63.
12. Brown RG, MacCarthy B, Jahanshahi M, et al. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol 1989;46:955-9.
13. Kidd D, Stewart G, Baldry J, et al. The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil 1995;17:10-14.
14. Ramaker C, Marinus J, Stiggelbaut AM, et al. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord 2002;17:867-76.
15. Hariz G-M, Lindberg M, Hariz MI, et al. Does the ADL part of the Unified Parkinson's Disease Rating Scale measure ADL? An evaluation in patients following pallidotomy and thalamic deep brain stimulation. Mov Disord 2002;18:373-8.
16. Lang AE, Benabid AL, Koller WC, et al. The core assessment program for intracerebral transplantation. Mov Disord 1995;10:527-8.
17. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:196-8.
19. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-6.
20. Raven JC. Guide to using the coloured progressive matrices. London: HK Lewis, 1965.
21. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987;6(suppl 8):8-120.
22. Caltagirone C, Gainotti G, Masullo C, et al. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand 1979;60:1-13.
23. Barcelo F, Sonz M, Molina V, et al. The Wisconsin Card Sorting Test and the assessment of frontal function: a validation study with event-related potentials. Neuropsychologia 1997;35:399-408.
24. Barbarotto R, Laiacona M, Frosio R, et al. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 1998;19:161-70.
25. Moro E, Scerrati M, Romita LMA, et al. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's Disease. Neurology 1999;53:85-90.
26. Capecci M, Passamonti L, Annesi F, et al. Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the Parkin gene. Mov Disord 2004;19:1450-2.
27. Volkmann J, Herzog J, Kopper F, et al. Introduction to the programming of deep brain stimulators. Mov Disord 2002;17(suppl 3):S181-7.
28. Olanow CW, Koller WC. An algorithm (decision free) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology. Neurology 1998;50(3 suppl 3):S1-57.
29. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56(11 suppl 5):S1-S88.
30. Ceravolo MG, Paoloni L, Provinciali L. Rehabilitation of parkinsonian patients. Funct Neurol 2001;16:157-62.
31. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology 1967;17:427-42.
32. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34.
33. Rodriguez-Oroz MC, Zamarbide I, Guridi J, et al. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004;75:1382-5.
34. Ford B, Winfield L, Pullman SL, et al. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 2004;75:1255-9.
35. Stowe RL, Wheatley K, Clarke CE, et al. Surgery for Parkinson's disease: lack of reliable clinical trial evidence. J Neurol Neurosurg Psychiatry 2003;74:519-21.
36. Tandberg E, Larsen JP, Nessler EG, et al. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995;10:541-9.
37. Schrog A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000;123(Pt 11):2297-305.
38. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-34.
39. Louis ED, Tang MX, Cote L, et al. Progression of parkinsonian signs in Parkinson's disease. Arch Neurol 1999;56:334-7.
40. Romito MA, Scerrati M, Costantino MF, et al. Long-term follow-up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-50.
41. Schwab JF, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson MC, eds. Third Symposium on Parkinson's Disease. Edinburgh: Churchill Livingstone, 1969:152-7.
42. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738-50.
43. Goetz CG, LeWitt PA, Weidenman M. Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program. Mov Disord 2003;18:1455-8.
44. Martinez-Martin P, Benito-Leon J, Alonso F, et al. Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable? Mov Disord 2003;18:985-92.
45. Biemans MAJE, Dekker J, van der Woude LHV. The internal consistency and validity of the self-assessment Parkinson's disease disability scale. Clin Rehabil 2001;15:221-8.
46. Wade DT. Epidemiology of disabling neurological disease: how and why does disability occur? J Neurol Neurosurg Psychiatry 1997;63(suppl):S11-18.
47. Marras C, Rochon P, Lang AE. Predicting motor decline and disability in Parkinson's disease. Arch Neurol 2002;59:1724-8.
48. Burn DJ. Depression in Parkinson's disease. Eur J Neurol 2002;9(suppl 3):44-54.
49. Okun MS, Green J, Saben R, et al. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J Neurol Neurosurg Psychiatry 2003;74:1584-6.
50. Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002;59:1427-9.
51. Saint-Cyr JA, Trepanier LL, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123(Pt 10):2091-108.
52. Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002;17:1084-5.
53. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease, Brain 2002;125:575-83.
54. Reardon KA, Shiff M, Kempster PA. Evolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years. Mov Disord 1999;4:605-11.
55. Rascol O, Goetz C, Koller W, et al. Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet 2002;359:1589-98.
56. Goetz CG, Stebbins GT, Blasucci LM. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord 2000;15:479-84.